Building on four decades of manufacturing expertise, Dano is investing in the next generation of immunological and biological products to address global public health priorities.
Dano's R&D strategy is focused on high-impact vaccine and biological categories aligned with global public health priorities.
Expanding our proven toxoid platform beyond Tetanus — developing combination and single-antigen products targeting Diphtheria, Pertussis, and other priority bacterial diseases for EPI and UIP programmes.
Developing multi-antigen combination formulations — including Td, DTP, and next-generation combinations — to reduce injection burden and improve programme compliance.
Leveraging our integrated DS+DP infrastructure to develop sterile biological drug products for proprietary and CMO pipelines, with a focus on parenteral presentations.
Actively evaluating and in-licensing novel vaccine technologies from international partners for local adaptation and commercialisation targeting disease areas with unmet needs.
Embedding ICH Q8–Q10 principles from earliest development stages, ensuring clear and defensible regulatory pathways to CDSCO, WHO PQ, and international market authorisations.
Our pipeline spans the marketed portfolio and active development programmes.
| Product | Research | Pre-clinical | Clinical | Registration | Marketed | Indication |
|---|---|---|---|---|---|---|
|
DANO-TT®
Tetanus Vaccine (Adsorbed)
|
Active immunisation against tetanus |
Deep expertise in fermentation-based toxin production, chemical inactivation, and purification of bacterial toxoids to pharmacopoeial and WHO TRS specifications.
Automated sterile filling lines with flexibility for multiple vial sizes and ampoule presentations, supporting proprietary and CMO programmes.
Experience with aluminium salt adjuvant systems for adsorbed vaccine formulations with ongoing evaluation of alternative adjuvant strategies.
Modern QC laboratories supporting full physicochemical, microbiological, and biological testing throughout the product lifecycle.
Our Business Development team evaluates in-licensing opportunities and collaborative R&D arrangements.
Whether you are looking for a partnership, need product information, or have a general query — our team is here to help.